Status:
UNKNOWN
A Multifaceted Telemedicine-Based Intervention to Improve Outcomes of Cancer Patients Admitted to the ICU
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Active Malignancies
Life Threatening Complication of the Malignancy or Its Treatments
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Admission to the intensive care unit (ICU) is a common event in patients treated for solid tumors or hematologic malignancies. A volume-outcome relationship has been shown in these patients, with a mo...
Eligibility Criteria
Inclusion
- Adult patients (\> 18 years old)
- Active malignancy;
- ICUs seeking for an advice must admit fewer than 30 patients with active cancer per year;
- Patients has been urgently admitted in the ICU for a life threatening complication of the malignancy or its treatments.
Exclusion
- Isolated HIV infection or AIDS;
- ICU admission complicating scheduled surgery,
- Treatment-limitation decisions at admission;
- No coverage by the French statutory health insurance system,
- Pregnant or breastfeeding
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
256 Patients enrolled
Trial Details
Trial ID
NCT05423795
Start Date
June 1 2022
End Date
December 1 2024
Last Update
June 21 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.